Ethics statement
The study was approved by the Ethics Committee “Comité de Protection des Personnes Est-III” under the number 2022-A01118-35 on June 09, 2022. At least one parent of each patient will provide written informed consent before inclusion. The University Hospital of Besancon is the trial sponsor. Results of the study will be submitted for publication in a peer-reviewed international medical journal.